Pharmacokinetics and Safety of Tigecycline in the Treatment of Clostridium Difficile Associated Diarrhea (CDAD)
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
This is a prospective, non-comparative, interventional, observational pilot study of the
safety and pharmacokinetics of intravenous (IV) tigecycline in conjunction with standard oral
therapy in patients with known mild to severe confirmed Clostridium difficile associated
diarrhea (CDAD).